Regeneron drugs in demand after Trump coronavirus treatment — but it’s not available to public
Patients are asking to join clinical trials of antibody-based COVID-19 drugs after U.S. President Donald Trump was treated last week with an experimental therapy from Regeneron Pharmaceuticals Inc, and on Wednesday he promised to make it … Read More